Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database - Yang, Qing; Wang, Junyan; Wang, Menghuan; Zhang, Shuyu; He, Qin-Qin (BMC pharmacology & toxicology, 2024)
Keywords: Adolescent; Adult; Adverse Drug Reaction Reporting Systems - statistics & numerical data; Adverse events; Aged; Analysis; Anti-Obesity Agents - adverse effects; Anti-Obesity Agents - therapeutic use; Bayesian analysis; Biomedical and Life Sciences; Biomedicine; Bupropion; Clinical medicine; Data base management systems; Databases, Factual; Diabetes; Digestive system; Digestive system diseases; Digestive System Diseases - chemically induced; Digestive System Diseases - epidemiology; Drug therapy; Drugs; Enzymes; FDA approval; Female; Gastrointestinal diseases; Health services; Humans; Liraglutide; Liraglutide - adverse effects; Liraglutide - therapeutic use; Male; Medical errors; Medical personnel; Middle Aged; Naltrexone; Obesity; Obesity - epidemiology; Overweight; Pancreatitis; Pharmacology/Toxicology; Pharmacovigilance; Regression analysis; Topiramate; Type 2 diabetes; United States - epidemiology; United States Food and Drug Administration; Weight control; Weight reducing preparations; Young Adult; United States; United Kingdom; United States--US; Obesity; Digestive adverse events; Anti-obesity medications; Pharmacovigilance; Disproportionality analysis; FDA adverse event reporting system database